Navigation Links
Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
Date:2/19/2009

SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report fourth quarter and year end 2008 financial results on Thursday, February 26, 2009, after the U.S. financial markets close.

Anadys will hold a conference call and webcast to discuss its fourth quarter and year end 2008 financial results and highlights and to provide an update on its development programs on Thursday, February 26, 2009 at 5:00 p.m. Eastern Standard Time. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 93047283. The webcast and telephone replay will be available through March 12, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in the areas of hepatitis C and oncology. Such forward-looking statements involve known and unknown risks, uncertainties and ot
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
3. Anadys Pharmaceuticals to Present at Bio Investor Forum
4. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
5. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
6. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
7. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
8. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
9. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
10. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
11. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Europe is one of the largest ... hence, irrigated land area. The agricultural sector is a ... around 30.0% of the total water use. The scale ... southern region, but far from negligible in most northern ... over 60.0% of the water use in most countries, ...
(Date:7/11/2014)... understand the best available treatment for patients, from a ... costly for taxpayers than the existing clinical trial process, ... Staa, carried out while he was a member of ... now based at The University of Manchester,s Health eResearch ... HTA ) today (Friday 11 July) looked at the ...
(Date:7/11/2014)... Salt Lake City, UT (PRWEB) July 11, 2014 ... hard at work at the Kilimanjaro Kids Community in Tanzania. ... children, 40 goats, 150 chickens, and two cows. HOP Founder, ... and provide education for some of the orphaned children he ... week, the HOP Team visited the children, who have all ...
(Date:7/11/2014)... being prescribed exercise as medicine, according to a ... activity is essential to reducing the risk of ... from QUT,s Institute of Health and Biomedical Innovation, ... physical and mental health, health professionals should be ... Professor Anderson and QUT,s Dr Charlotte Seib co-authored ...
(Date:7/11/2014)... July 11, 2014 Emily Johnson, owner of the ... Her fitness boot camp has held two charity workout ... on Saturday, July 26th, from 7:15 - 8:30 at Col Summers ... first charity boot camp session raised $510 for Medical Teams International. ... non-profit I Have a Dream. On July 26th, Johnson and ...
Breaking Medicine News(10 mins):Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:Exercise is the best medicine: QUT study 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 3
... Council will launch its 2009 June National Safety Month with free enrollment ... , "Alive at ... "First Aid and CPR with AED," basic training ... "Alive at 25 Parent Program" is an engaging, science-based course that educates ...
... is certain: there,s no place like home. Now, a study ... is true for rats. Although inner city rodents appear to ... majority of their lives. , Like any major city, Baltimore ... But scientists from the Johns Hopkins Bloomberg School of Public ...
... staff connect using technology powered by 100 ... solutionsJERICHO, N.Y., May 26 Optimum Lightpath, ... for New York metropolitan area businesses, today ... solution available exclusively through Optimum Lightpath to ...
... the two illnesses , , TUESDAY, May 26 (HealthDay News) ... heart disease has been discovered by German scientists. , ... has been known for years, but a genetic link ... Kiel team found that the two diseases share a ...
... Scheduled for Monday June 1 at 1:00 PM ET ... Calif., May 26 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of new oncology therapeutics, today announced ... 2 clinical trials in frontline acute myeloid leukemia (AML) ...
... dental expert notes importance of regular oral care to protect ... Results from a 2008 Gallup-Healthways poll(1) show that 42 percent ... 12 months, even though the American Dental Association recommends having ... percent of all Americans responded that they did not see ...
Cached Medicine News:Health News:National Safety Council Launches June National Safety Month With Free Training 2Health News:Optimum Lightpath(SM) and GetWellNetwork(R) Transform Hospital Bedside Care with Launch of Interactive Patient Care Service 2Health News:Optimum Lightpath(SM) and GetWellNetwork(R) Transform Hospital Bedside Care with Launch of Interactive Patient Care Service 3Health News:Optimum Lightpath(SM) and GetWellNetwork(R) Transform Hospital Bedside Care with Launch of Interactive Patient Care Service 4Health News:Gum Disease, Heart Disease Share Genetic Link 2Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 2Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 3Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 4Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 2Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 3
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
Anodized aluminum. Durable and lightweight with built-in protection against rust. Security locks ensure against accidental opening. Silicone matting/V-strips and bumper guards hold instruments in pla...
... Storage in bottom of ... accessories, etc. Anodized aluminum. Durable ... against rust. Security locks ensure ... and bumper guards hold instruments ...
Size: 3 x 6 inches. Depth: 1 inch. Sterilizable plastic tray with silicone matting for supporting and protecting instruments....
Size: 6 x 10 inches. Depth: 7 inches. Sterilizable plastic tray with silicone matting for supporting and protecting instruments....
Medicine Products: